Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00135200 · OUTCOME

Progression Free Survival Time

Clinical Trial of Consolidation Treatment With Iodine I 131 Tositumomab for Multiple Myeloma · Source last updated 2025-04-30

This outcome was registered, but no numerical results were posted in the captured record.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
up to approximately 15 years after treatment

What was measured

Disease progression or death from Multiple Myeloma from start of study treatment

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
denom Units Selected
Participants
description
Disease progression or death from Multiple Myeloma from start of study treatment
reporting Status
NOT_POSTED
time Frame
up to approximately 15 years after treatment
title
Progression Free Survival Time
type
SECONDARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice